-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WHf2vkjztG+Q1spo8rC/AumZh4YcQnzBdLGLiXSXntcLj7P/6XTyHOK04DEuJsIb T8Cg4k4HmntLCE0Y9AUUQQ== 0001127602-09-005601.txt : 20090303 0001127602-09-005601.hdr.sgml : 20090303 20090303170738 ACCESSION NUMBER: 0001127602-09-005601 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20090227 FILED AS OF DATE: 20090303 DATE AS OF CHANGE: 20090303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BERTHOUX CHRISTOPHER CENTRAL INDEX KEY: 0001199981 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15943 FILM NUMBER: 09652527 MAIL ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL INC CENTRAL INDEX KEY: 0001100682 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 061397316 FISCAL YEAR END: 1227 BUSINESS ADDRESS: STREET 1: 261 BALLARDVALE STREET CITY: WILMINGTON STATE: MA ZIP: 01867 BUSINESS PHONE: 9786586000 MAIL ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19991208 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2009-02-27 0001100682 CHARLES RIVER LABORATORIES INTERNATIONAL INC CRL 0001199981 BERTHOUX CHRISTOPHER 251 BALLARDVALE STREET WILMINGTON MA 01887 1 Executive Vice President Common Stock 2009-02-27 4 A 0 10000 0 A 25918 D Common Stock 2009-02-28 4 A 0 500 0 A 26418 D Common Stock 2009-02-28 4 F 0 104 24.80 D 26314 D Common Stock 2009-02-28 4 F 0 191 24.80 D 26123 D Common Stock 2009-02-28 4 F 0 80 24.80 D 26043 D Stock Options (Right to Buy) 24.80 2009-02-27 4 A 0 39500 0 A 2010-02-27 2016-02-27 Common Stock 39500 39500 D Restricted Common Shares vest equally over four years beginning one year from date of issuance. Reflects final payment of performance awards issued as 50% Common Stock and 50% Restricted Common Stock. The Restricted Common Stock Shares shall vest on 2/28/10. Options vest equally over 4 years beginning 1 year from date of grant. /s/Christophe Berthoux 2009-03-03 EX-24 2 doc1.txt EXHIBIT 24 POWER OF ATTORNEY SECTION 16 FILINGS Know all by these presents, that the undersigned hereby constitutes and appoints David P. Johst and Matthew L. Daniel as the undersigned's true and lawful attorneys-in-fact to: (1) prepare, execute in the undersigneds name and on the undersigneds behalf, and submit to the U.S. Securities and Exchange Commission (the SEC) a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation of the SEC; (2) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of Charles River Laboratories International, Inc. (the Company), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder, and any other forms or reports the undersigned may be required to file in connection with the undersigneds ownership, acquisition, or disposition of securities of the Company; (3) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (4) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in- fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants the attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact,or such attorney- in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 13th day of February, 2009. /s/Christophe Berthoux Signature -----END PRIVACY-ENHANCED MESSAGE-----